– ALUNBRIG has Potential to Expand its Indication in ALK+ Metastatic Non-Small Cell Lung Cancer –

– Prescription Drug User Fee Act (PDUFA) Target Action Date Set for June 23, 2020 –

CAMBRIDGE, Mass. & OSAKA, Japan-Friday 28 February 2020 [ AETOS Wire ]

(BUSINESS WIRE)-- Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) today announced that the U.S. Food and Drug Administration (FDA) has granted priority review for the company’s supplemental New Drug Application (sNDA) to expand the use of ALUNBRIG (brigatinib) as a first-line treatment for patients with anaplastic lymphoma kinase-positive (ALK+) metastatic non-small cell lung cancer (NSCLC) as detected by an FDA-approved test. ALUNBRIG is a next-generation tyrosine kinase inhibitor (TKI) that was designed to target and inhibit ALK genetic alterations.

“ALK+ NSCLC is a rare and serious form of lung cancer that is complex to treat. Whi ... Read more »

− Investigational medicine TAK-062 is an oral computationally engineered super glutenase designed to improve the digestion of gluten

− Successful “build to buy” relationship adds second investigational therapy to Takeda’s pipeline for the potential treatment of uncontrolled celiac disease

 On-Track to Hit $100M in Annual Recurring Revenue in Early 2020 Just Over Four Years After Inception, New Investment Will Help HeadSpin Deepen Position Within Cloud Ecosystems

PALO ALTO, Calif.-Saturday 29 February 2020 [ AETOS Wire ]

(BUSINESS WIRE)-- HeadSpin, the company that ensures flawless connected experiences enabled by web, mobile, IoT and 5G, today announced a $60 million Series C funding round led by Dell Technologies Capital and ICONIQ Capital with participation from institutional investors Tiger Global Management, Kearny Jackson, and Alpha Square Group. The round brings the total amount raised since inception to $117 million. HeadSpin will use the funding to develop new product offerings, expand into new market segments, and deepen position within cloud ecosystems.

HeadSpin also announced that Nikesh Arora, Chairman CEO of Palo Alto Networks, has joined the company Board of Directors as Chairman of the Board. Arora is the for ... Read more »

PARIS-Saturday 29 February 2020 [ AETOS Wire ]

(BUSINESS WIRE) -- Schlumberger Limited (NYSE: SLB) will hold a conference call on April 17, 2020 to discuss the results for the first quarter ending March 31, 2020.

The conference call is scheduled to begin at 8:30 a.m. US Eastern time and a press release regarding the results will be issued at 7:00 a.m. US Eastern time.

To access the conference call, listeners should contact the Conference Call Operator at +1 (844) 721-7241 within North America or +1 (409) 207-6955 outside of North America approximately 10 minutes prior to the start of the call and the access code is 4013483.

A webcast of the conference call will be broadcast simultaneously at www.slb.com/irwebcast on a listen-only basis. Listeners should log in 15 minutes prior to the start of the call to test their browsers and register for the webcast. Following the end of the conference call, a replay will be available at www.slb.com/irwebcast until ... Read more »